Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : LIFE crawled time : 13:00 save search
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 0.0%
H: 1.5%
C: -5.0%
pharma conference year financial results
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
Published: 2024-02-21 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 1.6%
H: 5.24%
C: 3.14%
pharma program trial
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
Published: 2024-01-29 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 0.0%
H: 3.16%
C: 2.53%
pharma cell
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
Published: 2024-01-18 (Crawled : 13:00) - globenewswire.com
WDAY A | $255.73 -0.42% -0.43% 1.2M
|
Technology Services
|
| O: 0.71%
H: 0.87%
C: 0.84%
PODD | $167.215 -0.03% -0.03% 650K
|
Health Technology
|
| O: 0.95%
H: 0.87%
C: 0.54%
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 1.72%
H: 0.0%
C: -4.05%
pharma
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -1.79%
H: 6.36%
C: 1.36%
pharma preclinical efzofitimod
aTyr Pharma to Present at March Investor Conferences
Published: 2023-03-08 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -0.48%
H: 3.11%
C: 1.67%
pharma
aTyr Pharma to Present at the Jefferies London Healthcare Conference
Published: 2022-10-25 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 0.0%
H: 4.43%
C: 2.53%
pharma conference
aTyr Pharma Announces Dosing of First Patient in Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis
Published: 2022-09-27 (Crawled : 13:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 2.83%
H: 0.0%
C: -4.12%
pharma study
aTyr Pharma to Present at the H.C. Wainwright 24th Annual Global Investment Conference 2022
Published: 2022-09-06 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -0.87%
H: 3.8%
C: 1.46%
pharma global conference
aTyr Pharma to Participate in Panel at National Institutes of Health Rare Disease Day®
Published: 2022-02-23 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 1.37%
H: 0.19%
C: -2.71%
day health rare disease pharma
aTyr Pharma to Present at Antibody Engineering & Therapeutics Conference
Published: 2021-12-10 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -4.24%
H: 0.0%
C: 0.0%
conference therapeutics antibody pharma
aTyr Pharma Announces Pricing of $75 Million Public Offering of Common Stock
Published: 2021-09-16 (Crawled : 13:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 8.72%
H: 23.72%
C: 10.76%
offering pharma
aTyr Pharma Announces Expansion of Research Collaboration with The Ohio State University
Published: 2021-08-10 (Crawled : 13:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: -0.83%
expansion collaboration research pharma
aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyr’s Anti-NRP2 Antibody ATYR2810
Published: 2021-04-14 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: 1.34%
H: 9.12%
C: 5.01%
antibody pharma
aTyr Pharma Presents Preclinical Research Showing Effects of ATYR2810 in Lung and Breast Cancer at the 2021 AACR Virtual Annual Meeting
Published: 2021-04-09 (Crawled : 13:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -1.62%
H: 9.18%
C: 5.88%
cancer research breast cancer preclinical pre-clinical
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2020 Financial ResultsManagement to host conference call and webcast on March 23rd at 5:00 pm EDT / 2:00 pm PDT
Published: 2021-03-16 (Crawled : 13:00) - biospace.com/
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -0.53%
H: 30.53%
C: 27.02%
financial results results conference
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2020 Financial Results
Published: 2021-03-16 (Crawled : 13:00) - globenewswire.com
LIFE | $1.595 -1.54% -1.57% 290K
|
Health Technology
|
| O: -0.53%
H: 30.53%
C: 27.02%
financial results results conference pharma
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.